BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14734115)

  • 21. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance.
    Gumperz JE
    Traffic; 2006 Jan; 7(1):2-13. PubMed ID: 16445682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T lymphocyte recognition of human group 1 CD1 molecules: implications for innate and acquired immunity.
    Sugita M; Brenner MB
    Semin Immunol; 2000 Dec; 12(6):511-6. PubMed ID: 11145856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.
    Adams EJ
    Curr Opin Immunol; 2014 Feb; 26():1-6. PubMed ID: 24556395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved.
    Park JJ; Kang SJ; De Silva AD; Stanic AK; Casorati G; Hachey DL; Cresswell P; Joyce S
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1022-6. PubMed ID: 14722359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insights into lipid antigen presentation.
    De Libero G; Mori L
    Trends Immunol; 2012 Mar; 33(3):103-11. PubMed ID: 22342205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular pathways of CD1 antigen presentation.
    Moody DB; Porcelli SA
    Nat Rev Immunol; 2003 Jan; 3(1):11-22. PubMed ID: 12511872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD1--a new paradigm for antigen presentation and T cell activation.
    Sugita M; Moody DB; Jackman RM; Grant EP; Rosat JP; Behar SM; Peters PJ; Porcelli SA; Brenner MB
    Clin Immunol Immunopathol; 1998 Apr; 87(1):8-14. PubMed ID: 9576005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c.
    Geho DH; Fayen JD; Jackman RM; Moody DB; Porcelli SA; Tykocinski ML
    J Immunol; 2000 Aug; 165(3):1272-7. PubMed ID: 10903726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.
    Roura-Mir C; Catálfamo M; Cheng TY; Marqusee E; Besra GS; Jaraquemada D; Moody DB
    J Immunol; 2005 Mar; 174(6):3773-80. PubMed ID: 15749918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system.
    Huang S; Cheng TY; Young DC; Layre E; Madigan CA; Shires J; Cerundolo V; Altman JD; Moody DB
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19335-40. PubMed ID: 22087000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of lipid antigen presentation by CD1.
    Jackman RM; Moody DB; Porcelli SA
    Crit Rev Immunol; 1999; 19(1):49-63. PubMed ID: 9987600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs.
    Sugita M; Jackman RM; van Donselaar E; Behar SM; Rogers RA; Peters PJ; Brenner MB; Porcelli SA
    Science; 1996 Jul; 273(5273):349-52. PubMed ID: 8662520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD1-Restricted T Cells at the Crossroad of Innate and Adaptive Immunity.
    Pereira CS; Macedo MF
    J Immunol Res; 2016; 2016():2876275. PubMed ID: 28070524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.
    Zeng Z; Castaño AR; Segelke BW; Stura EA; Peterson PA; Wilson IA
    Science; 1997 Jul; 277(5324):339-45. PubMed ID: 9219685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
    Porcelli SA; Modlin RL
    Annu Rev Immunol; 1999; 17():297-329. PubMed ID: 10358761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The intricacies of self-lipid antigen presentation by CD1b.
    Shahine A
    Mol Immunol; 2018 Dec; 104():27-36. PubMed ID: 30399491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The versatility of the CD1 lipid antigen presentation pathway.
    Chancellor A; Gadola SD; Mansour S
    Immunology; 2018 Jun; 154(2):196-203. PubMed ID: 29460282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separate pathways for antigen presentation by CD1 molecules.
    Sugita M; Grant EP; van Donselaar E; Hsu VW; Rogers RA; Peters PJ; Brenner MB
    Immunity; 1999 Dec; 11(6):743-52. PubMed ID: 10626896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group 1 CD1-restricted T cells take center stage.
    Young MH; Gapin L
    Eur J Immunol; 2011 Mar; 41(3):592-4. PubMed ID: 21341260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.